Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study

Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study

Acute promyelocytic leukemia (APL), is now highly curable with treatment approaches that include all-trans retinoic acid (ATRA). The high incidence of APL in the Hispanics suggests an association with genetic variants in this population. Information on second primary malignancies (SPMs) in patients...

Full description

Bibliographic Details
Main Authors: Luana Lenzi, Lisa Lee-Jones, Maruf A. Mostofa, Diancarlos P. de Andrade, Raul C. Ribeiro, Bonald C. Figueiredo
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
leukemia
APL
acute promyelocytic
ATRA
chemotherapy
Online Access:https://www.mdpi.com/2072-6694/12/12/3610

Internet

https://www.mdpi.com/2072-6694/12/12/3610

Similar Items